 | Articles: Drug Trials |
TYSABRI Multiple Sclerosis Clinical Trial Hold Lifted by FDA; Biogen Idec and Elan to Resume Clinical Trial Dosing in MS
Elan, 02/16/06
New 48 Week Clinical Trial Data Reported Comparing Reyataz (Atazanavir Sulfate), With Or Without Ritonavir, In Treatment-Naïve Patients
Bristol Myers-Squibb Company, 02/16/06
Survival Benefit Linked to Estrogen in Women Treated With XYOTAX
CTI, 02/16/06
 | | Sponsor |
Phase I Evaluation of Oral and Intravenous Vinorelbine in Pediatric Cancer Patients: A Report from the Children's Oncology Group
Clinical Cancer Research, 02/15/06
Phase I Study of the Taxane BMS-188797 in Combination with Carboplatin Administered Every 3 Weeks in Patients with Solid Malignancies
Clinical Cancer Research, 02/15/06
Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
Clinical Cancer Research, 02/15/06
ARIAD Initiates First Clinical Trial of Oral AP23573 in Combination with Doxorubicin Chemotherapy
Ariad, 02/15/06
Increased Toxicity With Gefitinib, Capecitabine, and Radiation Therapy in Pancreatic and Rectal Cancer: Phase I Trial Results
Journal of Clinical Oncology, 02/14/06
ARIXTRA was effective and well tolerated in acutely ill medical patients — treatment reduced risk of venous thromboembolism (VTE)
GlaxoSmithKline, 02/14/06
New Data From Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease With Conjugated Estrogens Alone in Any Age Group Studied
Wyeth, 02/14/06
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
